510(k) Report

510(k) · Cleared

Cleared

Opticage Interbody Fusion Device, Model Series 9070

K133583510(k) SpecialCleared Feb 10, 201481-day reviewClass II21 CFR 888.3080

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Interventional Spine, Inc. · MAX Intervertebral Fusion Device With Bone Graft, Lumbar

Cleared on Feb 10, 2014 as substantially equivalent to K113527 (Interventional Spine, Inc., 2012) and 1 other predicate after an 81-day review. Its family tree reaches back 12 generations to 1984.

Decided
Feb 10, 2014
Review
81 days
Class
Class II
Product code
MAX
Recalls
None
Predicates
2

Its longest line of descent runs back 12 generations to K841189 (1984). 23 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 12 generations backK841189 Oec/Rezaian Spinal FixatorOrthopedic Equipment Co., Inc. · 1984
  2. 8 generations between
  3. 3 generations backK093242 Patriot Transcontinental Llif SpacerGlobus Medical, Inc. · 2009
  4. 2 generations backK102293 Caliber SpacerGlobus Medical, Inc. · 2011
  5. 1 generation backK113527 Opticage Interbody Fusion DeviceInterventional Spine, Inc. · 2012
  6. This deviceK133583 Opticage Interbody Fusion Device, Model Series 9070Interventional Spine, Inc. · 2014
Show all 12 generations
  1. Root · 12 generations backK841189 Oec/Rezaian Spinal FixatorOrthopedic Equipment Co., Inc. · 1984
  2. 11 generations backK990148 Stackable Cage SystemDepuy Motech Acromed · 1999
  3. 10 generations backK003043 Surgical Titanium Mesh SystemDepuyacromed · 2001
  4. 9 generations backK020522 Modification to Surgical Titanium Mesh SystemDepuyacromed · 2002
  5. 8 generations backK030833 Depuy Acromed VBR SystemDepuyacromed · 2003
  6. 7 generations backK031635 Depuy Acromed VBR SystemDepuyacromed · 2003
  7. 6 generations backK041722 Modification to VBR Spinal SystemDepuy Spine, Inc. · 2004
  8. 5 generations backK052746 Concorde VBR Spinal SystemDepuy Spine, Inc. · 2005
  9. 4 generations backK090899 Depuy Spine Lateral SystemDepuy Spine, Inc. · 2009
  10. 3 generations backK093242 Patriot Transcontinental Llif SpacerGlobus Medical, Inc. · 2009
  11. 2 generations backK102293 Caliber SpacerGlobus Medical, Inc. · 2011
  12. 1 generation backK113527 Opticage Interbody Fusion DeviceInterventional Spine, Inc. · 2012
  13. This deviceK133583 Opticage Interbody Fusion Device, Model Series 9070Interventional Spine, Inc. · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−12K841189Oec/Rezaian Spinal FixatorOrthopedic Equipment Co., Inc.1984—
−11K990148Stackable Cage SystemDepuy Motech Acromed1999—
−10K003043Surgical Titanium Mesh SystemDepuyacromed2001—
−9K020522Modification to Surgical Titanium Mesh SystemDepuyacromed2002—
−8K030833Depuy Acromed VBR SystemDepuyacromed2003—
−7K031635Depuy Acromed VBR SystemDepuyacromed2003—
−6K041722Modification to VBR Spinal SystemDepuy Spine, Inc.2004—
−5K052746Concorde VBR Spinal SystemDepuy Spine, Inc.2005—
−4K090899Depuy Spine Lateral SystemDepuy Spine, Inc.2009—
−3K093242Patriot Transcontinental Llif SpacerGlobus Medical, Inc.2009—
−2K102293Caliber SpacerGlobus Medical, Inc.2011—
−1K113527Opticage Interbody Fusion DeviceInterventional Spine, Inc.2012—
0 (this device)K133583Opticage Interbody Fusion Device, Model Series 9070Interventional Spine, Inc.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200010
200120
200310
200720
200830
201310
FIG. 1 — Lineage of K133583, 1984–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MAX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MAX device

  1. #1 K203714 NuVasive Thoracolumbar Interbody Systems…score 102.5 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K113527Opticage Interbody Fusion Device
Summary page 1
…The additional sizes described in this submission are substantially equivalent to the Opticage Expandable Interbody Fusion Device, Model Series 9070, cleared under K1 13527 and K132479. Description of the Device Subject to Premarket Notification The Opticage Expandable Interbody Fusion Device, Mode…
Interventional Spine, Inc.2012—
*K132479Opticage Interbody Fusion Device, Model 9080-00
Summary page 1
…l sizes described in this submission are substantially equivalent to the Opticage Expandable Interbody Fusion Device, Model Series 9070, cleared under K1 13527 and K132479. Description of the Device Subject to Premarket Notification The Opticage Expandable Interbody Fusion Device, Model Series 907…
Interventional Spine, Inc.2013—

Also cleared against K113527: 7 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 30 years and passes through 6 companies; a new generation was cleared every 1.1 years on median.
  • 1 of the 23 ancestors has a recall of any class.
  • 7 other devices also cite its predicate K113527.

How does its category compare?

All MAX devices

MAX Intervertebral Fusion Device With Bone Graft, Lumbar: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · MAX

29in 2025

2007: 72008: 352009: 312010: 292011: 492012: 482013: 582014: 582015: 532016: 642017: 762018: 642019: 602020: 562021: 532022: 412023: 302024: 382025: 292026 (partial year): 18
2007high 76 (2017) · low 7 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MAX

85in 2025

2007: 86 days median2008: 88 days median2009: 102 days median2010: 137 days median2011: 98 days median2012: 69 days median2013: 102 days median2014: 115 days median2015: 113 days median2016: 124 days median2017: 116 days median2018: 114 days median2019: 131 days median2020: 106 days median2021: 109 days median2022: 95 days median2023: 87 days median2024: 91 days median2025: 85 days median2026 (partial year): 95 days median
2007high 137 (2010) · low 69 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MAX

5in 2025

2008: 22009: 92011: 32012: 11, 1 Class I2014: 32015: 12016: 62017: 12018: 42019: 12022: 12024: 12025: 5
2007high 11 (2012) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · MAX

811in 2025

2007: 122008: 192009: 902010: 1542011: 2012012: 3272013: 3802014: 3662015: 5242016: 6472017: 5962018: 6162019: 6992020: 6402021: 6222022: 6182023: 5762024: 7292025: 811
2007high 811 (2025) · low 12 (2007)2025

MAUDE reports naming product code MAX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007786012
20083588219
200931102990
2010291370154
201149983201
2012486911 (1)327
2013581020380
2014581153366
2015531131524
2016641246647
2017761161596
2018641144616
2019601311699
2020561060640
2021531090622
202241951618
202330870576
202438911729
202529855811
202618950—

What is it indicated for?

The Opticage Interbody Fusion Device is a posterior lumbar intervertebral body fusion device and is indicated for use with autogenous bone graft in patients with degenerative disc disease (DDD) at one or two contiguous levels from L2-S1. These DDD patients may also have up to Grade I spondylolisthesis or retrolisthesis at the involved level(s). The Opticage Interbody Fusion Device can be implanted via posterior or transforaminal approach. DD is defined…

Read the full statement (164 words)

The Opticage Interbody Fusion Device is a posterior lumbar intervertebral body fusion device and is indicated for use with autogenous bone graft in patients with degenerative disc disease (DDD) at one or two contiguous levels from L2-S1. These DDD patients may also have up to Grade I spondylolisthesis or retrolisthesis at the involved level(s). The Opticage Interbody Fusion Device can be implanted via posterior or transforaminal approach.

DD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. Candidates for surgery should be skeletally mature and have had six months of conservative treatment. These patients may have had primary or secondary surgery, but no previous fusion at the involved levels.

The device is not intended to be used as a stand-alone device. It must be used with supplemental internal spinal fixation systems that have been cleared for use in the lumbar spine (i.e. facet screw fixation systems, facet compression devices and posterior pedicle screw and rod systems).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K133583: Opticage Interbody Fusion Device, Model Series 9070.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K133583

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026